These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31217369)

  • 21. The role of helper and regulatory T cells in the pathogenesis of vitiligo.
    Basak PY; Adiloglu AK; Ceyhan AM; Tas T; Akkaya VB
    J Am Acad Dermatol; 2009 Feb; 60(2):256-60. PubMed ID: 19022528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutant HSP70 reverses autoimmune depigmentation in vitiligo.
    Mosenson JA; Zloza A; Nieland JD; Garrett-Mayer E; Eby JM; Huelsmann EJ; Kumar P; Denman CJ; Lacek AT; Kohlhapp FJ; Alamiri A; Hughes T; Bines SD; Kaufman HL; Overbeck A; Mehrotra S; Hernandez C; Nishimura MI; Guevara-Patino JA; Le Poole IC
    Sci Transl Med; 2013 Feb; 5(174):174ra28. PubMed ID: 23447019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines.
    Grimes PE; Morris R; Avaniss-Aghajani E; Soriano T; Meraz M; Metzger A
    J Am Acad Dermatol; 2004 Jul; 51(1):52-61. PubMed ID: 15243524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune-modulatory effects of lenalidomide inhibited the progression of lesions in a vitiligo mouse model.
    Pervaiz N; Kaur H; Parsad D; Kumar R
    Pigment Cell Melanoma Res; 2021 Sep; 34(5):918-927. PubMed ID: 33522688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.
    Campione E; Lanna C; Diluvio L; Cannizzaro MV; Grelli S; Galluzzo M; Talamonti M; Annicchiarico-Petruzzelli M; Mancini M; Melino G; Candi E; Schiavone G; Wang Y; Shi Y; Bianchi L
    Cell Cycle; 2020 Feb; 19(3):257-267. PubMed ID: 31905036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baicalin and geniposide attenuate atherosclerosis involving lipids regulation and immunoregulation in ApoE-/- mice.
    Liao P; Liu L; Wang B; Li W; Fang X; Guan S
    Eur J Pharmacol; 2014 Oct; 740():488-95. PubMed ID: 24991786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo.
    Richmond JM; Strassner JP; Zapata L; Garg M; Riding RL; Refat MA; Fan X; Azzolino V; Tovar-Garza A; Tsurushita N; Pandya AG; Tso JY; Harris JE
    Sci Transl Med; 2018 Jul; 10(450):. PubMed ID: 30021889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments.
    Custurone P; Di Bartolomeo L; Irrera N; Borgia F; Altavilla D; Bitto A; Pallio G; Squadrito F; Vaccaro M
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of tumor necrosis factor-α in the pathogenesis of vitiligo.
    Camara-Lemarroy CR; Salas-Alanis JC
    Am J Clin Dermatol; 2013 Oct; 14(5):343-50. PubMed ID: 23912226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFN-γ, IL-21, and IL-10 co-expression in evolving autoimmune vitiligo lesions of Smyth line chickens.
    Shi F; Erf GF
    J Invest Dermatol; 2012 Mar; 132(3 Pt 1):642-9. PubMed ID: 22113479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotics Drive Microbial Imbalance and Vitiligo Development in Mice.
    Dellacecca ER; Cosgrove C; Mukhatayev Z; Akhtar S; Engelhard VH; Rademaker AW; Knight KL; Le Poole IC
    J Invest Dermatol; 2020 Mar; 140(3):676-687.e6. PubMed ID: 31472106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo.
    Wang XX; Wang QQ; Wu JQ; Jiang M; Chen L; Zhang CF; Xiang LH
    Br J Dermatol; 2016 Jun; 174(6):1318-26. PubMed ID: 26801009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased systemic and epidermal levels of IL-17A and IL-1β promotes progression of non-segmental vitiligo.
    Bhardwaj S; Rani S; Srivastava N; Kumar R; Parsad D
    Cytokine; 2017 Mar; 91():153-161. PubMed ID: 28082234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baicalin Attenuates IL-17-Mediated Acetaminophen-Induced Liver Injury in a Mouse Model.
    Liao CC; Day YJ; Lee HC; Liou JT; Chou AH; Liu FC
    PLoS One; 2016; 11(11):e0166856. PubMed ID: 27855209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HO-1 regulates the function of Treg: Association with the immune intolerance in vitiligo.
    Zhang Q; Cui T; Chang Y; Zhang W; Li S; He Y; Li B; Liu L; Wang G; Gao T; Li C; Jian Z
    J Cell Mol Med; 2018 Sep; 22(9):4335-4343. PubMed ID: 29974998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo.
    Tembhre MK; Sharma VK; Sharma A; Chattopadhyay P; Gupta S
    Clin Chim Acta; 2013 Sep; 424():27-32. PubMed ID: 23680073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the elevated IFN-γ in vitiligo patients by human anti- IFN-γ monoclonal antibody hampers direct cytotoxicity in melanocyte.
    Ng CY; Chan YP; Chiu YC; Shih HP; Lin YN; Chung PH; Huang JY; Chen HK; Chung WH; Ku CL
    J Dermatol Sci; 2023 Jun; 110(3):78-88. PubMed ID: 37221109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo.
    Yang L; Wei Y; Sun Y; Shi W; Yang J; Zhu L; Li M
    Acta Derm Venereol; 2015 Jul; 95(6):664-70. PubMed ID: 25721262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
    van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM
    J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of chemokines and the corresponding receptors in vitiligo: A pilot study.
    Yang L; Yang S; Lei J; Hu W; Chen R; Lin F; Xu AE
    J Dermatol; 2018 Jan; 45(1):31-38. PubMed ID: 29115683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.